Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
25mg Pack Size. Group: Bioactive Small Molecules, Biochemicals, Research Organics & Inorganics. Formula: C15H14FN3O3. CAS No. 78755-81-4. Prepack ID 90029044-25mg. Molecular Weight 303.29. See USA prepack pricing.
Flumazenil
Flumazenil is a competitive GABAA receptor antagonist, used in the treatment of benzodiazepine overdoses. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Ro 15-1788. CAS No. 78755-81-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-B0009.
Flumazenil
Imidazodiazepine which selectively blocks the central effects of classic benzodiazepines. It is used as benzodiazepine antagonist. Group: Biochemicals. Alternative Names: 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic Acid Ethyl Ester; Anexate; Flumazepil; Flumenazil; Lanexat; Mazicon; Ro 15-1788; Ro 15-1788/000; Ro 151788; Ro 1722; Ro 41-8157; Romazicon. Grades: Highly Purified. CAS No. 78755-81-4. Pack Sizes: 10mg. US Biological Life Sciences.
Worldwide
Flumazenil EP Impurity B
Flumazenil EP Impurity B. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate. CAS No. 131666-45-0. Molecular formula: C15H15N3O4. Mole weight: 301.3. Catalog: APB131666450.
A competitive blocker of benzodiazepine activation of inhibitory GABAergic synpases (ID50 = 200ug/kg/i.p). Binds to the benzodiazepine site of GABAA receptors. Enhances GABAA-receptor mediated currents and antagonizes the enhancing effects of benzodiapine agonist flurazepam. Exhibits fast association and dissociation from the benzodiazepine binding site. Permeates the blood brain barrier, however, the level of uptake may depend on efflux effects of p-glycogprotein transporter. Group: Biochemicals. Grades: Highly Purified. CAS No. 78755-81-4. Pack Sizes: 10mg. Molecular Formula: C??H??FN?O?. US Biological Life Sciences.
Worldwide
Flumazenil Impurity 12
Flumazenil Impurity 12. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1248271-71-7. Molecular formula: C10H11FN2O3. Mole weight: 226.21. Catalog: APB1248271717.
Flumazenil Liposome
Flumazenil is a 1,4-imidazole benzodiazepine derivative and a benzodiazepine (BZD) receptor antagonist. This product is a pre-formulated liposome with flumazeni. It is only for research purposes and for the injection to laboratory animals. Group: Drug-loaded liposome. Categories: liposomes, niosomes, ethosomes, and transfersomes.
Flumazenil Related Compound A
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Flumazenil Related Compound B
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Flumazenil Related Compound C
United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards.
Defluoro flumazenil isothiocyanate
Defluoro flumazenil isothiocyanate. Group: Biochemicals. Alternative Names: 5,6-Dihydro-8-isothiocyanato-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester. Grades: Highly Purified. CAS No. 954107-48-3. Pack Sizes: 1mg, 2mg, 5mg, 10mg, 25mg. Molecular Formula: C16H14N4O3S. US Biological Life Sciences.
Worldwide
Defluoro flumazenil isothiocyanate
Defluoro flumazenil isothiocyanate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 5,6-Dihydro-8-isothiocyanato-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic Acid Ethyl Ester. Product Category: Heterocyclic Organic Compound. CAS No. 954107-48-3. Molecular formula: C16H14N4O3S. Mole weight: 342.37. Purity: 0.96. IUPACName: ethyl 8-isothiocyanato-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate. Canonical SMILES: CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)N=C=S)C. Product ID: ACM954107483. Alfa Chemistry ISO 9001:2015 Certified.
1-Bis(4-fluorophenyl)methyl Piperazine
1-Bis(4-fluorophenyl)methyl Piperazine (Flumazenil EP Impurity A) is a chemical reagent used in the synthesis of novel tubulin polymerization inhibitors. Also used in the synthesis of novel benzhydrylpiperazine carboxamide derivatives. Impurity of F455200. Group: Biochemicals. Grades: Highly Purified. CAS No. 27469-60-9. Pack Sizes: 1g, 10 g. Molecular Formula: C17H18F2N2. US Biological Life Sciences.
Bretazenil (Ro16-6028) is an imidazopyrrolobenzodiazepine anxiolytic drug that is derived from the benzodiazepine family and was invented in 1988. It is most closely related in structure to the benzodiazepine antagonist flumazenil, although its effects are somewhat different. It is classed as a high-potency benzodiazepine due to its high-affinity binding to benzodiazepine binding sites where it acts as a partial agonist. Its profile as a partial agonist and preclinical trial data suggests that it may have a reduced adverse effect profile. In particular, bretazenil has been proposed to cause a less strong development of tolerance and withdrawal syndrome. Bretazenil differs from traditional 1,4-benzodiazepines by being a partial agonist and because it binds to α1, α2, α3, α4, α5, and α6 subunit-containing GABAA receptor benzodiazepine receptor complexes. 1,4-benzodiazepines bind only to α1, α2, α3 and α5 GABAA benzodiazepine receptor complexes. Group: Salt. Alternative Names: ((2R,3R)-3-(Benzoyloxy)-4,4-difluoro-5-oxotetrahydrofuran-2-yl)methyl benzoate; 2-Deoxyl-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate; 2-Deoxy-2,2-Difluoro-d-Erythro-Pentofuranos-1-Ulose-3,5-Dibenzoate; [(2R,3R)-3-benzoyloxy-4,4-difluoro-5-oxooxolan-2-yl]methyl benzoate; 2-Deoxy-2,2-difluoro-D-erythro-pentonic acid &gamm
Perfluoro-1-iodohexane
Bretazenil (Ro16-6028) is an imidazopyrrolobenzodiazepine anxiolytic drug that is derived from the benzodiazepine family and was invented in 1988. It is most closely related in structure to the benzodiazepine antagonist flumazenil, although its effects are somewhat different. It is classed as a high-potency benzodiazepine due to its high-affinity binding to benzodiazepine binding sites where it acts as a partial agonist. Its profile as a partial agonist and preclinical trial data suggests that it may have a reduced adverse effect profile. In particular, bretazenil has been proposed to cause a less strong development of tolerance and withdrawal syndrome. Bretazenil differs from traditional 1,4-benzodiazepines by being a partial agonist and because it binds to α1, α2, α3, α4, α5, and α6 subunit-containing GABAA receptor benzodiazepine receptor complexes. 1,4-benzodiazepines bind only to α1, α2, α3 and α5 GABAA benzodiazepine receptor complexes. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Tridecafluoro-1-iodohexane;PERFLUORO-N-HEXYL IODIDE;1-Iodotridecafluorohexane;Perfluorohexyl iodide;1-iodo-tridecafluoro-hexane. Product Category: Heterocyclic Organic Compound. Appearance: Liquid. CAS No. 355-43-1. Molecular formula: C6F13I. Mole weight: 445.95. Purity: 98. Density: 2.063. Product ID: ACM355431. Alfa Chemis
Sodium Oleate
Sodium Oleate. Synonyms: Sodium oleate;oleic acid sodium salt;sodium cis-9-octadecanoate;eunatrol;Lunac SO 90L. CAS No. 143-19-1. Product ID: CDC10-0473. Molecular formula: C18H33NaO2. Category: Cosmetic Surfactants. Product Keywords: Cosmetic Ingredients; Cosmetic Surfactants; Sodium Oleate; CDC10-0473; 143-19-1; C18H33NaO2; Sodium oleate; oleic acid sodium salt; sodium cis-9-octadecanoate; eunatrol; Lunac SO 90L; 205-591-0; MFCD00004438; 143-19-1. Color: White. EC Number: 205-591-0. Physical State: Powder. Storage: -20ºC. Boiling Point: 359.999ºC at 760 mmHg. Melting Point: 232-235ºC(lit.). Density: 0.9 g/cm3. Product Description: Bretazenil (Ro16-6028) is an imidazopyrrolobenzodiazepine anxiolytic drug that is derived from the benzodiazepine family and was invented in 1988. It is most closely related in structure to the benzodiazepine antagonist flumazenil, although its effects are somewhat different. It is classed as a high-potency benzodiazepine due to its high-affinity binding to benzodiazepine binding sites where it acts as a partial agonist. Its profile as a partial agonist and preclinical trial data suggests that it may have a reduced adverse effect profile. In particular, bretazenil has been proposed to cause a less strong development of tolerance and withdrawal syndrome. Bretazenil differs from traditional 1,4-benzodiazepines by being a partial agonist and because it binds to α1, α2, α3,
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.